Like to be kept up to date? Sign up to our bi-monthly newsletter here!
Subscribe to our newsletter
Publications on Synthetic... Action plan Synthetic Nanomaterials Report by the Federal Council of 9 April 2008 Synthetic Nanomaterials Risk Assessment and Risk ManagementBasic report for the Swiss Action Plan, 2007
Nanomedicine: The Minuten... Tiny particles that can fight cancer or that can easily pass through any interface within our body are a great promise for medicine. But there is little
CLINAM 25.-28.10.20, 12th European and Global CLINAM‐Summit, Basel, Programme
Save the date: NME21 Due to the sanitary situation, Nanomed Europe 21 (NME21) is postponed to Tuesday, September 7 – Thursday, September 9, 2021, still in St. Gallen, Switzerland: www.nme21.eu Do not miss this
Need help with the regist... eREACHNano is a new free web tool focused on helping small and medium-sized companies that may lack sufficient in-house expertise on the regulation covering nanomaterials.
Microplastics and Nanopla... Recently, the European Commission published a study that provides further information on the intentional uses of microplastic particles in products and the risks they pose to human
Crucial results for coron... Empa researcher Peter Wick, Head of the Particles-Biology Interactions Laboratory in St. Gallen and Director of contactpointnano.ch talks to Empa Quarterly about recent antibody studies, which are
Characterizing Nanopartic... Live Webinar, Thursday 19 November, 15:00 (Zürich). Guest speaker Dr. Sandor Balog, Details, Please register for this event using this link
Subscribe to our newslett... Like to be kept up to date? Sign up to our bi-monthly newsletter here!